Izmo missed its FY26 breakeven target for Izmo Micro. The CEO didn't explain why.
The division stayed in the red despite two prior years of explicit guidance, as the company shifts focus to a multi-year photonics ramp.
What's new
- Izmo Micro order book stands at ₹42 crore with a pipeline exceeding ₹100 crore.
- FY26 revenue rose 26.8% to ₹284.88 crore; Q4 was the highest quarterly revenue in company history.
- Management now guides for consolidated EBITDA margins of 20-25% in FY27, up from 19.6%.
Themes from the call
Credibility
Management broke two consecutive years of breakeven guidance for Izmo Micro without acknowledging the miss or revising the thesis.
Demand
The photonics order book of ₹42 crore and pipeline of ₹100+ crore signal real customer pull, but execution timelines are long.
Capital allocation
Planned ₹125 crore capex to expand capacity from ₹150 crore to ₹1,200 crore is a large bet for a company with ₹47 crore net profit.
Guidance watch
- Izmo Micro FY27 revenue guided at ₹45-50 crore, which would imply 148% growth.
- Consolidated EBITDA margin guided at 20-25% for FY27.
- A FrogData divestment previously promised for FY26 has been pushed to an unspecified later date.
Risk flags
- The missed breakeven target for Izmo Micro was not addressed, raising questions about the reliability of forward guidance.
- The planned ₹125 crore capex is substantial relative to the company's current profit base.
- Management downplayed its quantum technology expertise, abandoning a near-term chip launch timeline in favor of a vague multi-year plan.
Key quotes
-
"This year we will break even. And next year onwards, you will see a 30% to 40% gross margin and at least 25% EBITDA."
— Sanjay Soni, MD, Nov 2025 call -
"While the full year profits reflect the investment phase nature of Izmo Micro... we are satisfied with the quality of our earnings growth."
— Sanjay Soni, MD, Jun 2026 call
The brief
Izmo's management missed its own breakeven target for the Izmo Micro division and didn't fess up. In June 2025 and November 2025, MD Sanjay Soni told investors the unit would break even in FY26. It didn't. The June 2026 call acknowledged an investment-phase loss but offered no explanation for the discrepancy. That's a credibility problem, not just a numbers miss.
The rest of the story is about a large, high-stakes pivot. Izmo Micro, the silicon photonics packaging unit, has a ₹42 crore order book and a pipeline exceeding ₹100 crore. The technology is real. A 32-channel high-density packaging breakthrough in August 2025 puts Izmo in a select global club. The TAM is enormous, reportedly $30 billion today growing to $80 billion. But the path from pilot orders to scaled profit is long, and management's credibility on timelines is already compromised.
The financials show a company investing ahead of revenue. FY26 consolidated revenue grew 26.8% to ₹284.88 crore, but net profit was flat year-on-year at ₹47.56 crore. Q4 was the highest quarterly revenue in company history, and that's the headline management wants to lead with. They're now guiding for FY27 EBITDA margins of 20-25%, up from 19.6%. They're also planning ₹125 crore in capex to expand addressable capacity from ₹150 crore to ₹1,200 crore. That's an eightfold increase, ramped over three years. For a company earning less than ₹50 crore in profit, it's a big bet.
Two other broken commitments deserve a flag. The FrogData divestment, promised for FY26 to attract large investors, has been pushed to an unspecified future date. And the quantum random number generator chip, once slated for a Q3/Q4 FY26 launch with IIT, has been pushed to a multi-year horizon. Management even walked back its earlier claims of quantum expertise. The pattern is clear: timelines slip, guidance is abandoned, and no one explains why.
Izmo's photonics opportunity is real. Its track record of hitting its own targets is not.